Anti-agalsidase antibodies Anticorps spécifique des myosites Myocarditis Analyses multidimensionnelles Lysosomal storage diseases Adjudication Humans Anti‐mitochondrial antibodies Skeletal muscle Myositis Abnormal movement Inclusion body myositis Case reports Data integration Autoimmunity CD8+T cells Myositis and muscle disease Active Antibodies Interferon Middle Aged Antisynthetase Amyotrophic lateral sclerosis Inflammatory myopathy IBM Aged Antiphospholipid syndrome Anti-drug antibodies Cancer Dermatomyositis Anti-IgE IgG Animals Amyotrophy AAV B-lymphocyte IMNM Auto-antibodies Adeno-associated virus Biomarker Agalsidase Male Machine learning Autoantibodies Cytokines DM Biomarqueurs Interstitial lung disease Aldostérone Acid-alpha-glucosidase Idiopathic inflammatory myopathies Bioelectrical impedance analysis Inborn errors of metabolism Multidisciplinarity Anti-synthetase syndrome Systems biology Biopsy AAV antibody Antibody responses Fabry disease Auto‐antibodies AAV vectors Immune checkpoint inhibitors Biomarkers Anti-interleukin-6 CD8+ T-bet+ cells Adult Female Arthritis Gene therapy Prognosis Polymyositis Outcome measures Autoantibody Auto-immunité Anémie hémolytique B cell homeostasis Anti-MDA5 autoantibodies Inflammation Muscle Antisynthétase Mass cytometry Myopathy Adeno-associated virus vector Deep immune profiling Antisynthetase syndrome Adeno-associated vector Anticorps anti-agalsidase AAV vector Anti-Mi2 Adverse drug reactions Acute Kidney Injury/epidemiology/etiology Sphingosine-1-phosphate Dependovirus/genetics/immunology AAV humoral immunity COVID-19 Immunotherapy Assisted communication devices Adolescence Aldosterone Autoimmune diseases